A New Voice for Autism Research in Washington
The Independent Autism Coordinating Committee (I‑ACC) convened its inaugural meeting in Washington, D.C., signaling a decisive shift in how autism research is approached. Formed swiftly by researchers and advocates, the I‑ACC emerged from frustration that the federal Interagency Autism Coordinating Committee (I‑ACC) had drifted away from scientific rigor.
21 Controversial Appointments
Secretary Robert F. Kennedy, Jr. added 21 new members to the federal committee—many of whom have linked vaccines to autism and champion unproven treatments. Critics argue that these appointments narrow the committee’s focus, leaving it a small, skeptical enclave rather than a representative body for the broader autism community.
Missing Priorities Highlighted
During its kickoff, I‑ACC members identified key gaps:
- Funding for rigorous therapy trials
- Improved communication tools between researchers, families, and clinicians
- Clarification on antidepressant use in autistic children
These priorities underscore a push toward evidence‑based research and practical solutions.
Federal Committee’s Postponement
The federal committee was slated to meet on the same day but postponed after learning of I‑ACC’s gathering. The delay underscored how the new group directly challenged Kennedy’s overhaul of the status quo.
Alleged Website Manipulations
Under Kennedy, CDC and FDA websites were reportedly altered to sow doubt about vaccine safety and remove warnings on dangerous autism therapies, such as chelation. These changes are viewed by critics as part of a broader effort to revive vaccine skepticism.
I‑ACC’s Mission
The committee aims to:
- Keep research grounded in evidence
- Protect taxpayer dollars from funding fringe ideas
- Prevent the current composition of the federal committee from stalling scientific progress and harming people with autism
Historical Context
The original I‑ACC, created in 2006 amid rising vaccine‑autism concerns, sought to unite researchers, families, and autistic individuals. The new committee strives to restore that collaborative spirit by countering ideological bias.
Representation Gaps
Both committees currently feature limited autistic representation: the federal committee has fewer members overall, while I‑ACC has only one. This underrepresentation weakens the community’s voice in shaping research priorities and policy decisions.
Call to Action
Critics warn that without robust advocacy, autistic people risk losing influence over the policies and studies that directly affect their lives.
